Active · established relationshipLatest completed snapshot · Jul 14 · 18:03 ET

MARKET-DISCOVERED GROUP

Clinical-Stage Biotech

THE TRADER READCAPR dominates an otherwise mixed group path

1 of 2 measured session-normalized paths align to the upside across 2.0 effective names. EWTX, CBIO are also moving with filing-linked members. Capital-flow agreement is 38%, so the basket is not yet clean. No verified headline preceded the measured move.

Price breadth1 up · 1 down+0.4% session-normalized median path

Capital-flow alignment38%Price breadth is not yet confirmed by flow

Activity nowHotActivity score 84/100 · lift 1.3×

Evidence depth3 episodesLow sample—context, not a validated playbook

EVIDENCE CLOCK

What happened, in timestamp order

2 timed events · 09:55–15:55 ET

TIMING READNo verified timestamped headline was found within 24 hours of the first measured price move in the available common-bar window. The move currently reads as market-led or unexplained.

10:00 ET
5-minute inferenceCAPR registered the first material upside path
+3.44% session path at the threshold · CAPR
11:15 ET
5-minute inferenceSTRO registered a material downside path
-1.39% session path at the threshold · STRO

THEME CONSTRUCTION

Broad move or one-stock disguise?

Session-normalized 5m paths

Observed movement is concentrated across 2.0 effective names. CAPR represents 53.6% of absolute path energy; 1 of 2 members align with the up relative path.

ConstructionConcentrated53.6% from the largest path

Effective names2.0 / 2Movement diversity after concentration

Direction breadth1/2 alignedupside relative path · 1 counter-moving

Largest moverCAPR 53.6%100.0% from the top two paths

CAPR53.6%Dominant mover · path +5.48% · basket +2.74pp

STRO46.4%Dominant mover · path -4.75% · basket -2.37pp

01 · WHAT IS HAPPENING

The move, the flow and who is driving it

Price breadth, unusual activity and signed capital flow are separate observations

HOW THE PRICE MOVE SPREAD

Observed session sequence

5-minute bars · inferred

10:00 ET
CAPR moved higher firstFirst member to clear the material path threshold · path +3.44%
11:15 ET
STRO registered a material lower path75m after the first price move · path -1.39%

Sequence inferred from aligned 5-minute price paths; it is not a causal ordering.

RELATIVE CO-MOVEMENT

How the members are behaving together

Session-normalized

Aug 19 · 09:55 ETMove visible 10:00 ETAug 19 · 15:55 ET

Group median +0.37%Strongest relative path CAPRWeakest relative path STRO

Observed member paths normalized to the session. The dashed marker shows when the median move first cleared a material threshold; shading marks the latest 20% of the observed window.

02 · WHY IT MATTERS

Why now and where the move could travel

Context and lead/lag links are evidence, not proof of causation or a forecast

WHY NOW

Verified recent context

0 items

No verified recent catalyst is attached to this move. The relationship may be market-led rather than news-led.

WHY THIS GROUP EXISTS

Shared filing context

No high-confidence shared filing driver is available. The market relationship is observed, but the cause remains unexplained.

CONFIRMATION NETWORK

Outsiders and cross-asset links

2 outsiders confirming

LESL → AGGInverse historical lead/lag · strength -0.16

LESL → CPERInverse historical lead/lag · strength -0.19

Filing-linked outsiders test whether the move is spreading beyond the established cohort.

EWTXMoving with group

CAPR · text peer

CBIOMoving with group

STRO · text peer

AKTXRelationship only · live confirmation unavailable

STRO · text peer

BCDARelationship only · live confirmation unavailable

CAPR · text peer

03 · WHO IS IN IT

Member participation

Unusual activity and daily price direction are shown separately

STROCAPR

2/2 active1 rising · 1 falling

MemberUnusual activityToday's moveRead now

STROSutro Biopharma, Inc.

Most unusual · 100/100

-7.2%

Dominant path moverActive in 100% of observed group sessions

CAPRCapricor Therapeutics, Inc.

Elevated · 73/100

+0.4%

Dominant path moverActive in 100% of observed group sessions

View exact member values

TICKER	Company	Role now	Today	Observed history	Trader interpretation
STRO	Sutro Biopharma, Inc.	Most unusual	-7.2%	100% of 9 sessions	Most unusual activity in this snapshot; performance direction may differ.
CAPR	Capricor Therapeutics, Inc.	Participating	+0.4%	100% of 9 sessions	Price participation with distributing signed flow.

04 · HAS THIS HAPPENED BEFORE

Identity history versus measured outcomes

Structural recurrence is not the same as a validated trading outcome

POINT-IN-TIME LIVE OUTCOMES

Live outcome ledger collecting

0/0 events completed

No completed point-in-time outcome is available yet. New live confirmations are now retained with their exact observation timestamp; statistics appear only after the corresponding candles complete.

Low structural sample

Only 3 completed episodes across 9 active sessions; treat history as context, not a validated playbook. These episode counts describe recurrence; the outcome ledger above is the only forward-performance evidence.

Structural support66 daysHow often the cohort identity was observed

Completed episodes3Separate periods of broad group activity

Active sessions9Completed session observations, not trades

2026-07-07 → 2026-07-102 active sessions100% composition consistency through the episode

2026-06-24 → 2026-07-015 active sessions66.7% composition consistency through the episode

2026-06-16 → 2026-06-172 active sessions100% composition consistency through the episode

MEMBER CONSISTENCY IN OBSERVED ACTIVE SESSIONS

CAPR100% · 3 episodes

STRO100% · 3 episodes